Filing Details

Accession Number:
0000950170-24-018246
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-21 18:46:13
Reporting Period:
2024-02-20
Accepted Time:
2024-02-21 18:46:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1815442 Kymera Therapeutics Inc. KYMR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1638474 W. Jeffrey Albers C/O Kymera Therapeutics, Inc.
200 Arsenal Yards Blvd., Suite 230
Watertown MA 02472
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-20 615 $10.34 615 No 4 M Direct
Common Stock Disposition 2024-02-20 615 $39.07 0 No 4 S Direct
Common Stock Acquisiton 2024-02-21 4,385 $10.34 4,385 No 4 M Direct
Common Stock Disposition 2024-02-21 4,385 $39.05 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-02-20 615 $0.00 615 $10.34
Common Stock Stock Option (Right to Buy) Disposition 2024-02-21 4,385 $0.00 4,385 $10.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,734 2030-07-28 No 4 M Direct
16,349 2030-07-28 No 4 M Direct
Footnotes
  1. These transactions were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. The shares underlying this stock option shall vest in forty-eight (48) equal monthly installments following the vesting commencement date of July 28, 2020, subject to the reporting person's continued service relationship through each vesting date.